Does LEVOMILNACIPRAN Cause Maternal exposure during pregnancy? 222 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 222 reports of Maternal exposure during pregnancy have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 16.1% of all adverse event reports for LEVOMILNACIPRAN.
222
Reports of Maternal exposure during pregnancy with LEVOMILNACIPRAN
16.1%
of all LEVOMILNACIPRAN reports
216
Deaths
109
Hospitalizations
How Dangerous Is Maternal exposure during pregnancy From LEVOMILNACIPRAN?
Of the 222 reports, 216 (97.3%) resulted in death, 109 (49.1%) required hospitalization, and 108 (48.6%) were considered life-threatening.
Is Maternal exposure during pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 222 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Maternal exposure during pregnancy?
CERTOLIZUMAB PEGOL (9,013)
ADALIMUMAB (7,518)
PREDNISONE (6,587)
METHOTREXATE (6,223)
RITUXIMAB (6,093)
INFLIXIMAB (6,061)
HYDROXYCHLOROQUINE (5,809)
FOLIC ACID (5,768)
TOCILIZUMAB (5,737)
LEFLUNOMIDE (5,643)
Which LEVOMILNACIPRAN Alternatives Have Lower Maternal exposure during pregnancy Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE